Your browser doesn't support javascript.
loading
Multiethnic Prediction of Nicotine Biomarkers and Association With Nicotine Dependence.
Bergen, Andrew W; McMahan, Christopher S; McGee, Stephen; Ervin, Carolyn M; Tindle, Hilary A; Le Marchand, Loïc; Murphy, Sharon E; Stram, Daniel O; Patel, Yesha M; Park, Sungshim L; Baurley, James W.
Afiliação
  • Bergen AW; Oregon Research Institute, Eugene, OR, USA.
  • McMahan CS; BioRealm, LLC, Walnut, CA, USA.
  • McGee S; School of Mathematical and Statistical Sciences, Clemson University, Clemson, SC, USA.
  • Ervin CM; BioRealm, LLC, Walnut, CA, USA.
  • Tindle HA; BioRealm, LLC, Walnut, CA, USA.
  • Le Marchand L; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Murphy SE; Veterans Health Administration-Tennessee Valley Healthcare System, Geriatric Research, Education and Clinical Center (GRECC), Nashville, TN, USA.
  • Stram DO; Cancer Epidemiology and University of Hawaii Cancer Center, University of Hawai'i, Honolulu, HI, USA.
  • Patel YM; Biochemistry, Molecular Biology, and Biophysics and Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
  • Park SL; Department of Preventive Medicine, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Baurley JW; Department of Preventive Medicine, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Nicotine Tob Res ; 23(12): 2162-2169, 2021 11 05.
Article em En | MEDLINE | ID: mdl-34313775
ABSTRACT

INTRODUCTION:

The nicotine metabolite ratio and nicotine equivalents are measures of metabolism rate and intake. Genome-wide prediction of these nicotine biomarkers in multiethnic samples will enable tobacco-related biomarker, behavioral, and exposure research in studies without measured biomarkers. AIMS AND

METHODS:

We screened genetic variants genome-wide using marginal scans and applied statistical learning algorithms on top-ranked genetic variants, age, ethnicity and sex, and, in additional modeling, cigarettes per day (CPD), (in additional modeling) to build prediction models for the urinary nicotine metabolite ratio (uNMR) and creatinine-standardized total nicotine equivalents (TNE) in 2239 current cigarette smokers in five ethnic groups. We predicted these nicotine biomarkers using model ensembles and evaluated external validity using dependence measures in 1864 treatment-seeking smokers in two ethnic groups.

RESULTS:

The genomic regions with the most selected and included variants for measured biomarkers were chr19q13.2 (uNMR, without and with CPD) and chr15q25.1 and chr10q25.3 (TNE, without and with CPD). We observed ensemble correlations between measured and predicted biomarker values for the uNMR and TNE without (with CPD) of 0.67 (0.68) and 0.65 (0.72) in the training sample. We observed inconsistency in penalized regression models of TNE (with CPD) with fewer variants at chr15q25.1 selected and included. In treatment-seeking smokers, predicted uNMR (without CPD) was significantly associated with CPD and predicted TNE (without CPD) with CPD, time-to-first-cigarette, and Fagerström total score.

CONCLUSIONS:

Nicotine metabolites, genome-wide data, and statistical learning approaches developed novel robust predictive models for urinary nicotine biomarkers in multiple ethnic groups. Predicted biomarker associations helped define genetically influenced components of nicotine dependence. IMPLICATIONS We demonstrate development of robust models and multiethnic prediction of the uNMR and TNE using statistical and machine learning approaches. Variants included in trained models for nicotine biomarkers include top-ranked variants in multiethnic genome-wide studies of smoking behavior, nicotine metabolites, and related disease. Association of the two predicted nicotine biomarkers with Fagerström Test for Nicotine Dependence items supports models of nicotine biomarkers as predictors of physical dependence and nicotine exposure. Predicted nicotine biomarkers may facilitate tobacco-related disease and treatment research in samples with genomic data and limited nicotine metabolite or tobacco exposure data.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tabagismo / Produtos do Tabaco Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tabagismo / Produtos do Tabaco Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article